Surgical Pledgets Market – By Material, By Application, By End Use – Global Forecast, 2025 to 2034

Surgical Pledgets Market Size

The global surgical pledgets market size was valued at USD 768.2 million in 2024 and is expected to exhibit growth at a CAGR of 5.7% from 2025 to 2034. The increasing number of surgical procedures globally, particularly in cardiovascular, orthopedic, and general surgeries, is a significant contributor.
 

As the global aging population rises, there is a greater demand for surgeries that require effective wound care, which pledgets provide. Additionally, advancements in surgical techniques and the shift towards minimally invasive surgeries drive the need for efficient wound closure solutions like surgical pledgets, which are critical in such procedures.
 

Another driver is the growing focus on improving patient outcomes and reducing complications such as hospital-acquired infections and wound dehiscence, where pledgets are widely used as a effective hemostasis and tissue sealing agent.
 

Regulatory approvals and the availability of pledgets in a variety of materials, such as PTFE, polyester, and Teflon, cater to the diverse needs of surgical applications, further expanding the market. Lastly, increasing healthcare investments and the availability of better healthcare facilities in emerging markets contribute to the market’s expansion.  
 

Surgical pledgets are small, absorbable or non-absorbable pads used in various surgical procedures to reinforce sutures, control bleeding, or provide additional tissue support. They are typically made from materials like polytetrafluoroethylene (PTFE), polyester, or Teflon. Surgical pledgets are particularly useful in cardiovascular, orthopedic, and general surgeries, helping to prevent suture pull-through, minimize tissue trauma, and promote effective wound healing.
 

Surgical Pledgets Market Trends

Cardiovascular conditions, including coronary artery disease, heart failure, and valvular diseases, are becoming increasingly common due to factors such as aging populations, poor lifestyle choices, and rising rates of obesity and diabetes. As a result, the demand for cardiovascular surgeries, including coronary artery bypass graft (CABG), heart valve repair, and other procedures, has surged. Surgical pledgets play a crucial role in these surgeries by reinforcing sutures, controlling bleeding, and supporting tissue during the closure process, which is essential for minimizing complications and promoting effective healing.
 

• Moreover, advancements in minimally invasive cardiac surgeries, which are preferred due to their quicker recovery times and reduced risk of complications, have further boosted the need for reliable wound closure solutions like surgical pledgets. With cardiovascular diseases being a leading cause of morbidity and mortality worldwide, the market for surgical pledgets is expected to continue growing, as these devices are integral to successful surgical outcomes.
   
• The increasing number of procedures, particularly in high-risk patients, reinforces the demand for high-quality, effective pledgets to ensure optimal healing and minimize post-surgical complications. As the prevalence of cardiovascular diseases continues to rise, so does the need for surgical pledgets, making them an essential component in the modern surgical toolkit.
   

Surgical Pledgets Market Analysis

Based on material, the market is segmented as polytetrafluoroethylene (PTFE), polyester, teflon, and other materials. The polytetrafluoroethylene (PTFE) segment is expected to drive business growth and expand at a CAGR of 6.1%, reaching over USD 593.3 million by 2034.
 

• PTFE is highly valued for its excellent biocompatibility, chemical resistance, and low friction, which make it ideal for use in surgeries requiring minimal tissue irritation and effective wound closure. These properties are particularly beneficial in cardiovascular and orthopedic surgeries, where precision and reliability are crucial.
   
• PTFE pledgets are also preferred for their durability and ability to support sutures without the risk of tissue damage or suture pull-through, which enhances post-surgical recovery and reduces complications.
   
• Moreover, as surgical techniques evolve, especially with the rise of minimally invasive procedures, PTFE’s versatility becomes even more critical. Its ability to maintain its integrity during complex procedures and provide effective hemostasis contributes to its growing demand.
   

Based on application, the surgical pledgets market is segmented as cardiovascular surgery, orthopedic surgery, thoracic surgery, general surgery, and other applications. The cardiovascular surgery segment is expected to drive business growth and expand at a CAGR of 5.9%, reaching over USD 499.1 million by 2034.
 

• The rising prevalence of cardiovascular diseases, including coronary artery disease, heart valve disorders, and atherosclerosis, is fueling the demand for cardiovascular surgeries such as coronary artery bypass grafting (CABG) and valve repair procedures. As these surgeries often involve high levels of bleeding and require precise suture placement, surgical pledgets play a vital role in reinforcing sutures and controlling bleeding, ensuring better surgical outcomes and reduced complications.
   
• The increasing preference for minimally invasive cardiovascular procedures is another factor contributing to the growth of the pledget market. These surgeries require advanced hemostatic solutions like surgical pledgets to prevent tissue trauma and improve recovery times.
   
• Furthermore, technological advancements in surgical techniques and innovations in pledget materials, such as absorbable or bioabsorbable pledgets, are driving market demand. The need for more effective, safer, and less invasive solutions in cardiovascular surgeries makes surgical pledgets an essential component in ensuring optimal results, thus contributing significantly to the growth of this market segment.

Based on end use, the surgical pledgets market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 61.7% in 2024.
 

• Hospitals account for a large proportion of complex surgeries, including cardiovascular, orthopedic, and general surgeries, which require reliable wound closure solutions like surgical pledgets. These institutions perform a high volume of both elective and emergency procedures, thereby creating significant demand for products that aid in tissue reinforcement, hemostasis, and preventing complications.
   
• Hospitals also tend to have more advanced medical infrastructure, which allows them to use a broader range of surgical technologies, including specialized pledgets made from materials like PTFE and polyester, ensuring the best outcomes for patients.
   
• Furthermore, hospitals are equipped with skilled surgical teams and often handle more critical and high-risk surgeries, necessitating effective wound care solutions to avoid complications such as infections and bleeding. This combination of high surgery volume, advanced medical infrastructure, and patient care needs positions the hospitals segment as a key segment in the market.

U.S. surgical pledgets market accounted for USD 255 million in 2024 and is anticipated to grow at a CAGR of 4.5% between 2025 to 2034.
 

• The increasing prevalence of chronic diseases such as cardiovascular conditions, diabetes, and obesity has led to a higher demand for surgeries, including those requiring complex wound closure solutions like surgical pledgets. As the population ages, there is a rising need for surgeries related to orthopedic, cardiovascular, and general procedures, all of which utilize pledgets to ensure effective wound healing and reduce complications.
   
• Additionally, the U.S. healthcare system focus on improving surgical outcomes and minimizing complications is contributing to the market's growth. Innovations in surgical techniques and a preference for minimally invasive surgeries have increased the demand for reliable and efficient wound closure devices. Surgical pledgets are critical in minimizing bleeding, reducing the risk of infection, and enhancing patient recovery.
• Furthermore, the U.S. has a well-established healthcare infrastructure with numerous hospitals, ambulatory surgical centers, and specialty clinics, all of which utilize pledgets in their surgical practices.
   

U.K. surgical pledgets market is projected to grow remarkably in the coming years.
 

• The rising prevalence of chronic diseases such as cardiovascular conditions, diabetes, and obesity has led to an increase in the number of surgeries, particularly in hospitals. This surge in surgical procedures creates a higher demand for surgical pledgets, which are essential for effective wound closure, hemostasis, and tissue support in complex surgeries like cardiovascular and orthopedic operations.
   
• Moreover, the U.K.'s advanced healthcare infrastructure, coupled with ongoing medical research and innovation in surgical technologies, is enhancing the adoption of specialized pledgets, particularly those made from bioabsorbable materials or designed for specific applications.
   
• The National Health Service (NHS) and private healthcare providers are investing in the latest surgical technologies and are increasingly focused on improving patient outcomes, which boosts demand for high-quality surgical products.
   

China holds a dominant position in the Asia Pacific surgical pledgets market.
 

• The rapidly expanding healthcare infrastructure in China supports a growing demand for surgical products, including pledgets, as the country invests heavily in its medical facilities and services.
   
• Additionally, the growing number of hospitals and surgical centers, coupled with advancements in medical technologies, enables healthcare providers to adopt more specialized surgical tools, including pledgets made from materials like PTFE and polyester.
   
• Moreover, China's aging population is another significant driver, as older individuals are more likely to require surgical procedures, further increasing the demand for surgical pledgets. The government's initiatives to improve healthcare access and quality, particularly in rural and underserved regions, also contribute to the market's expansion. As the country continues to modernize its healthcare system and enhance the capabilities of its medical workforce, the market in China is poised for sustained growth.
   

Surgical Pledgets Market Share

The market is dominated by several leading companies that are recognized for their advanced product offerings and global reach. Prominent players such as Johnson & Johnson MedTech (Ethicon), B. Braun Melsungen AG, and Medtronic hold significant market shares due to their strong product portfolios and extensive distribution networks. These companies lead the market through their innovations in wound closure products, including pledgets made from materials like PTFE and polyester, which are widely used in various surgical procedures. Additionally, smaller players are emerging, focusing on regional markets and offering niche products, contributing to the overall competitive dynamics of the market. This competition and innovation are expected to drive continued growth in the sector.
 

Surgical Pledgets Market Companies

Prominent players operating in the surgical pledgets industry include:

• B. Braun
• Becton, Dickinson and Company
• DeRoyal
• Dolphin Sutures
• Gore
• Henry Schein
• Johnson and Johnson
• Medline
• Medtronic
• Peters Surgical
• Teleflex
   

Surgical Pledgets Industry News:

• In March 2024, Eurazeo reached an agreement to sell its entire stake in Peters Surgical to Advanced Medical Solutions Group plc (AMS), a company specializing in tissue-healing technologies. This acquisition will create a broader range of surgical products, including surgical pledgets, benefiting both patients and surgeons.
   
• In April 2023, Aziyo Biologics, Inc. entered into a distribution agreement with LeMaitre Vascular, Inc., a provider of vascular devices and services. Under this agreement, Aziyo granted LeMaitre exclusive distribution rights in the United States for its cardiovascular products, including Tyke, the only extracellular matrix cleared for neonatal and infant patch, pledget, and intracardiac repair.
   

The surgical pledgets market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Material

• Polytetrafluoroethylene (PTFE)  
• Polyester
• Teflon
• Other materials

Market, By Application

• Cardiovascular surgery
• Orthopedic surgery  
• Thoracic surgery
• General surgery
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE